You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Patent: 10,241,117


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,241,117
Title:Methods for quantifying polypeptides using mass spectrometry
Abstract: A method for identifying a polypeptide a specimen can include (i) treating a specimen suspected of including an insulin with a base; (ii) extracting a first fraction of the treated specimen by solid phase extraction using a mixed mode or polymeric reversed-phase media and a first solvent including an acid; (iii) separating a component of the first fraction by liquid chromatography using a chromatographic surface including a hydrophobic surface group and one or more ionizable modifiers, and a second solvent including an acid; and (iv) analyzing the component of the first fraction by mass spectroscopy, thereby identifying the polypeptide, if present, using a signal corresponding to a sequence fragment ion from the polypeptide. The signal can correspond to an intact multiply charged precursor fragment selected in a first quadrupole and its corresponding sequence fragment ion selected in a final quadrupole.
Inventor(s): Chambers; Erin E. (North Brookfield, MA), Stapels; Martha (Bellingham, MA), Mather; Joanne (Millis, MA)
Assignee: WATERS TECHNOLOGIES CORPORATION (Milford, MA)
Application Number:15/965,613
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Claims and Patent Landscape of United States Patent 10,241,117

Introduction

Patents are a crucial component of intellectual property law, providing inventors with exclusive rights to their inventions. To delve into the specifics of United States Patent 10,241,117, it is essential to understand the structure and requirements of a patent, as well as the broader patent landscape.

What is a Patent?

A patent grants its owner the exclusive right to make, use, import, sell, or offer for sale the invention covered by the patent. This exclusivity is granted in exchange for the public disclosure of the invention[1].

Key Components of a Patent

Specification and Written Description

The specification must adequately describe the invention, enabling a person skilled in the relevant technology to make and use it. This includes detailed textual descriptions and drawings that illustrate the invention[1].

Enablement

The specification must enable a person in the field of the relevant technology to make and use the invention. This ensures that the invention is not kept as a trade secret but is disclosed in sufficient detail[1].

Novelty and Nonobviousness

The invention must be novel, meaning it cannot be the same as something known in the prior art. Additionally, it must be nonobvious, meaning it cannot be an obvious extension of the prior art[1].

Patent Claims

Patent claims define the scope of the patent right and are the most critical part of the patent. These claims must be clear and specific, setting forth what the inventor regards as their invention[1].

Analyzing the Claims of United States Patent 10,241,117

To analyze the claims of this patent, one must review the patent document itself, focusing on the claims section.

Independent and Dependent Claims

The claims section will include independent claims that stand alone and define the invention, as well as dependent claims that reference and incorporate the limitations of previous claims. Understanding the hierarchy of these claims is crucial for determining the scope of the patent[1].

Claim Interpretation

The interpretation of patent claims is governed by legal precedents, such as the case of Festo Corporation v. Shoketsu Kinzoku Kogyo Kabushiki Co. Ltd., which highlights the importance of narrowing amendments to claims elements during patent prosecution. These amendments can significantly limit the scope of patent claims by eliminating the doctrine of equivalents and invoking prosecution history estoppel[2].

The Patent Landscape

Growth in Patent Applications

The number of patent applications has been increasing steadily, driven by technological innovation and facilitated by advancements in technology such as word processing and remote electronic database searching. This growth has led to a complex patent landscape where understanding and communicating one's patent property is increasingly challenging[2].

Increasing Number of Claims

Patent applications now often include several hundred claims, with some applications having claims in the thousands. This trend is partly due to legal precedents that encourage detailed claim drafting to avoid limitations on claim scope[2].

Automated Patent Analysis

To manage the complexity of patent claims, automated systems like the Patent Matrix software have been developed. These systems can import patent claims, parse them into their hierarchy, and provide compression and expansion functionality to facilitate rapid review[2].

Patent Term Adjustments and Double Patenting

Patent Term Adjustments (PTA)

Patent term adjustments can extend the term of a patent due to delays caused by the Patent Office during prosecution. However, these adjustments must be carefully managed to avoid issues of obviousness-type double patenting (ODP), which prevents a subsequent patent from being granted on the same invention or an obvious modification thereof[3].

Obviousness-Type Double Patenting (ODP)

The Federal Circuit has emphasized that U.S. patent law entitles an inventor to only one patent on each invention. To avoid ODP, patent owners must disclaim any term in subsequent patent applications that would effectively extend the term of already-issued patents through terminal disclaimers[3].

Emerging Technologies and Patent Landscapes

Synthetic Biology

In emerging fields like synthetic biology, the patent landscape is complex and rapidly evolving. Traditional methods of patent landscape analysis face limitations, and comprehensive searches of full patent texts are necessary to capture the full scope of activity in these areas[4].

Critical Analysis of United States Patent 10,241,117

Legal Requirements

To ensure the validity of the patent, the claims and specification must meet the legal requirements of clarity, enablement, novelty, and nonobviousness. Any failure to meet these requirements can lead to the patent being invalidated.

Competitive Position

Understanding the claims of this patent is crucial for determining its competitive position within the broader patent landscape. This involves analyzing the scope of the claims, the technology covered, and how it compares to prior art and other related patents.

Enforcement and Litigation

The rights conferred by the patent must be enforced through litigation if necessary. This includes addressing issues of direct infringement, infringement under the doctrine of equivalents, induced infringement, and contributory infringement in federal district court or before the International Trade Commission (ITC)[1].

Key Takeaways

  • Patent Structure: A patent includes a specification, drawings, and claims that define the scope of the invention.
  • Legal Requirements: Claims must be clear, enable a person skilled in the art to make and use the invention, be novel, and nonobvious.
  • Patent Landscape: The number of patent applications and claims is increasing, making automated analysis tools essential.
  • Patent Term Adjustments: Care must be taken to avoid ODP issues when applying for PTAs.
  • Emerging Technologies: Comprehensive patent landscape analysis is necessary in fields like synthetic biology.

FAQs

What are the key components of a patent?

The key components include the specification, drawings, and claims. The specification must describe the invention in detail, while the claims define the scope of the patent right.

Why is the number of patent claims increasing?

The number of patent claims is increasing due to legal precedents that encourage detailed claim drafting to avoid limitations on claim scope and the growing complexity of technological innovations.

What is obviousness-type double patenting (ODP)?

ODP is a doctrine that prevents a subsequent patent from being granted on the same invention or an obvious modification thereof. It is crucial to avoid ODP by disclaiming any term in subsequent patent applications that would extend the term of already-issued patents.

How do patent term adjustments affect the patent term?

Patent term adjustments can extend the term of a patent due to delays caused by the Patent Office during prosecution. However, these adjustments must be managed carefully to avoid ODP issues.

Why is automated patent analysis important?

Automated patent analysis is important because it helps reduce the amount of information users need to review, facilitating rapid and consistent review of claims in a growing and complex patent landscape.

Sources

  1. Congressional Research Service, "Patent Law: A Handbook for Congress," September 16, 2020.
  2. Google Patents, "US20110138338A1 - Patent Claims Analysis System and Method."
  3. Mintz, "Federal Circuit Puts the Onus on Patent Owners to Disclaim Patent," September 7, 2023.
  4. bioRxiv, "Synthetic Biology - Mapping the Patent Landscape," November 30, 2018.

More… ↓

⤷  Subscribe

Details for Patent 10,241,117

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 June 07, 2000 ⤷  Subscribe 2032-04-18
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 January 19, 2001 ⤷  Subscribe 2032-04-18
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 April 23, 2004 ⤷  Subscribe 2032-04-18
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.